Office of Biotechnology Activities; Office of Science Policy; Office of the Director; Notice of a Meeting of the NIH Blue Ribbon Panel, 10293-10294 [2010-4724]

Download as PDF Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism, Initial Review Group Neuroscience Review Subcommittee. Date: June 7–8, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Beata Buzas, PhD. Scientific Review Officer, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Rm 2081, Rockville, MD 20852. 301–443–0800. bbuzas@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) Dated: February 26, 2010. Jennifer Spaeth, Director, Office Federal Advisory Committee Policy. [FR Doc. 2010–4587 Filed 3–4–10; 8:45 am] Name of Committee: National Institute of Child Health and Human Development, Initial Review Group, Function, Integration, and Rehabilitation Sciences Subcommittee. Date: March 22, 2010. Time: 8:30 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Anne Krey, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892. 301–435– 6908. ak41o@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: February 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health erowe on DSK5CLS3C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. Jkt 220001 Name of Committee: National Institute of Environmental Health Sciences, Special Emphasis Panel, Breast Cancer Center Review Committee. Date: March 11–12, 2010. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Little America Hotel Salt Lake City, 500 South Main Street, Salt Lake City, UT 84101. Contact Person: Linda K. Bass, Scientific Review Administrator Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute Environmental Health Sciences, P. O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541– 1307, bass@niehs.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: February 24, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–4672 Filed 3–4–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M National Institute of Environmental Health Sciences; Notice of Closed Meeting 14:45 Mar 04, 2010 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. [FR Doc. 2010–4539 Filed 3–4–10; 8:45 am] BILLING CODE 4140–01–M VerDate Nov<24>2008 10293 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 National Institutes of Health Office of Biotechnology Activities; Office of Science Policy; Office of the Director; Notice of a Meeting of the NIH Blue Ribbon Panel The purpose of this notice is to inform the public about a meeting of the NIH Blue Ribbon Panel To Advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories at Boston University E:\FR\FM\05MRN1.SGM 05MRN1 10294 Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices Medical Center. The meeting will be held on Friday, March 19, 2010, at the National Institutes of Health, Building 31, 31 Center Drive, Floor 6C, Room 6, Bethesda, MD 20892, from approximately 8:30 a.m. to 2 p.m. This meeting is the second in a series of public meetings with the National Research Council to review the ongoing supplementary risk assessment study. It was originally scheduled to take place on February 12, 2010, but had to be postponed due to extreme weather conditions on the East Coast. Signup for public comment will begin at approximately 8 a.m. In the event that time does not allow for all those interested in presenting oral comments, anyone may file written comments using the following address below. An agenda and slides for the meeting may be obtained prior to the meeting by connecting to https:// nihblueribbonpanel-bumcneidl.od.nih.gov/. For additional information concerning this meeting, please contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of Science Policy, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985; telephone 301–496– 9838; e-mail lewallenl@od.nih.gov. Dated: March 1, 2010. Amy P. Patterson, Director, Office of Biotechnology Activities, National Institutes of Health. [FR Doc. 2010–4724 Filed 3–4–10; 8:45 am] BILLING CODE 4140–01–P for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIDCD. Date: March 26, 2010. Open: 7:30 a.m. to 8 a.m. Agenda: Reports from institute staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Room F1/ F2, Bethesda, MD 20892. Closed: 8 a.m. to 4:30 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Room F1/ F2, Bethesda, MD 20892. Contact Person: Andrew J. Griffith, Ph.D., MD., Director, Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, 5 Research Court, Room 1A13, Rockville, MD 20850, 301–496–1960, griffita@nidcd.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) Dated: March 1, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2010–4767 Filed 3–4–10; 8:45 am] erowe on DSK5CLS3C1PROD with NOTICES National Institute on Deafness and Other Communication Disorders; Notice of Meeting BILLING CODE 4140–01–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDCD. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended VerDate Nov<24>2008 14:45 Mar 04, 2010 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0054] Strengthening the Center for Devices and Radiological Health’s 510(k) Review Process; Public Meeting; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. SUMMARY: The Food and Drug Administration (FDA) is extending to March 19, 2010, the comment period for PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 the notice that appeared in the Federal Register of Wednesday, January 27, 2010 (75 FR 4402). In the notice, FDA requested comments on a number of identified challenges associated with the 510(k) process. The agency is taking this action to allow interested persons additional time to submit comments. DATES: Submit written or electronic comments and information by March 19, 2010. ADDRESSES: Submit written comments or information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments or information to https:// www.regulations.gov. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993, 301–796–6313, e-mail: james.swink@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of January 27, 2010 (75 FR 4402), FDA published a notice announcing a public meeting on February 18, 2010, and the opening of a public docket to receive comments on key challenges related to the premarket notification (or 510(k)) process for the review of medical devices. Specific questions for comment were listed and interested persons were invited to submit comments by March 5, 2010. At this time, the agency is extending the comment period until March 19, 2010, to continue to receive public comments. Comments submitted to the docket will assist in identifying actions that the Center for Devices and Radiological Health can consider taking to strengthen the 510(k) process. II. Submission of Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) written or electronic comments regarding this document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. All comments submitted to the public docket are public information and may be posted to FDA’s Web site at https:// www.fda.gov for public viewing. Comments are to be identified with the docket number found in brackets in the heading of this document. In addition, E:\FR\FM\05MRN1.SGM 05MRN1

Agencies

[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Pages 10293-10294]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4724]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities; Office of Science Policy; 
Office of the Director; Notice of a Meeting of the NIH Blue Ribbon 
Panel

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel To Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University

[[Page 10294]]

Medical Center. The meeting will be held on Friday, March 19, 2010, at 
the National Institutes of Health, Building 31, 31 Center Drive, Floor 
6C, Room 6, Bethesda, MD 20892, from approximately 8:30 a.m. to 2 p.m.
    This meeting is the second in a series of public meetings with the 
National Research Council to review the ongoing supplementary risk 
assessment study. It was originally scheduled to take place on February 
12, 2010, but had to be postponed due to extreme weather conditions on 
the East Coast.
    Signup for public comment will begin at approximately 8 a.m. In the 
event that time does not allow for all those interested in presenting 
oral comments, anyone may file written comments using the following 
address below.
    An agenda and slides for the meeting may be obtained prior to the 
meeting by connecting to https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information concerning this meeting, 
please contact Ms. Laurie Lewallen, Advisory Committee Coordinator, 
Office of Biotechnology Activities, Office of Science Policy, Office of 
the Director, National Institutes of Health, 6705 Rockledge Drive, Room 
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail 
lewallenl@od.nih.gov.

    Dated: March 1, 2010.
Amy P. Patterson,
Director, Office of Biotechnology Activities, National Institutes of 
Health.
[FR Doc. 2010-4724 Filed 3-4-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.